2018 Pathology Review: Breast, Soft Tissue, Orthopedic and GI Pathology for the General Pathologist – A Video CME Teaching Activity

• Differentiate benign breast disease and atypical proliferative lesions.
• Discuss liver biopsies in the post-HCV era.
• Achieve a better understanding of HER in GI malignancies and comparisons to breast.
• Prepare for colon cancer and universal screening for Lynch syndrome.
• Identify conditions to consider before surgical pathology subspecialty sign-out.
• Discuss breast cancer predictive factor testing (ER, PR & HER2).
• Analyze myxoid soft tissue tumors and peripheral nerve sheath tumors.
• Identify key features of genomic testing in breast cancer diagnosis and treatment planning.
• Describe sclerosing lesions of the breast.
• Discuss the utility of cytogenetic and FISH studies in workup of adipocytic lesions.
• Review differential diagnoses and pitfalls in fatty tumors.
• Review the appropriate use (and potential pitfalls) of MDM2 FISH studies in the work-up of a spindle cell malignancy in the retroperitoneum.
• Discuss bone-forming and cartilage-forming soft tissue tumors, as well as sarcomas that may occasionally produce matrix.
• Discuss the differential diagnosis of a spindle cell sarcoma with herringbone/fascicular growth.
• Discuss peripheral nerve sheath tumors, fibrohistiocytic neoplasms and vascular lesions.
• Review new entities such as soft tissue angiofibroma and biphenotypic sinonasal sarcoma.
• Review entities such as fibroepithelial stromal polyp, cellular angiofibroma, mammary-type myofibroblastoma, angiomyofibroblastoma and aggressive angiomyxoma, as well as their mimics.

Topics & Speakers:

Session 1

Benign Breast Disease: Atypical Proliferative Lesion: Diagnosis and Breast Cancer Risk

David G. Hicks, M.D.

Sclerosing Lesions of the Breast

David G. Hicks, M.D.

Session 2

Genomic in Breast Cancer Diagnosis and Treatment Planning: Is this an Opportunity to Enhance the Role of Pathologists in Multidisciplinary Care?

David G. Hicks, M.D.

Breast Cancer Predictive Factor Testing (ER, PR & HER2): Bridging the Gap Between Diagnosis and Management

David G. Hicks, M.D.

Session 3

Ancillary Breast Cancer Studies: Rogue Cases, Challenges, Pitfalls and Trouble Shooting

David G. Hicks, M.D.

Challenging Breast Pathology Case Studies

David G. Hicks, M.D.

HER2 in GI Malignancies: Comparison to Breast and Review Guidelines

Christa L. Whitney-Miller, M.D.

Liver Biopsies in the Post-HCV Era

Christa L. Whitney-Miller, M.D.

Session 4

Colon Cancer and Universal Screening for Lynch Syndrome: Are you Ready?

Christa L. Whitney-Miller, M.D.

Surgical Pathology Subspecialty Sign-Out: Things to Consider Before Taking the Plunge

Christa L. Whitney-Miller, M.D.

Session 5

Cutaneous Soft Tissue Tumors and Their Mimics

Karen Fritchie, M.D.

Lipomatous Tumors

Karen Fritchie, M.D.

Session 6

Intra-abdominal and Retroperitoneal Spindle Cell Tumors

Karen Fritchie, M.D.

Matrix Forming Mesenchymal Lesions

Karen Fritchie, M.D.

Session 7

New Entities in Soft Tissue Pathology

Karen Fritchie, M.D.

Genital Stromal Tumors and Soft Tissue Summary

Karen Fritchie, M.D.

Session 8

The Pathology of Skeletal Lesions: An Integrated Approach to Differential Diagnosis Part 1

David G. Hicks, M.D.

The Pathology of Skeletal Lesions: An Integrated Approach to Differential Diagnosis Part 2

David G. Hicks, M.D.